2.20
Vor Biopharma Inc Borsa (VOR) Ultime notizie
Is Vor Biopharma Inc. a good long term investmentOverwhelming profit margins - PrintWeekIndia
Vor Biopharma Inc. Stock Analysis and ForecastMassive profits - PrintWeekIndia
What analysts say about Vor Biopharma Inc. stockExceptional profit potential - Autocar Professional
What drives Vor Biopharma Inc. stock priceFree Stock Selection - PrintWeekIndia
Vor Biopharma Announces Key Leadership Changes - TipRanks
Vor Biopharma Inc.'s (NASDAQ:VOR) top holders are insiders and they are likely disappointed by the recent 14% drop - Yahoo Finance
H.C. Wainwright Upgrades Vor Biopharma (VOR) to a Buy, Sets a $3 Price Target - MSN
Vor Bio Appoints Biotech Industry Leaders Alexander (Bo) Cumbo and Michel Detheux, Ph.D. to Board of Directors - Stock Titan
Vor Biopharma's Strategic Turnaround and the Case for Immediate Investment - AInvest
Vor Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - AInvest
10 Hot Penny Stocks to Invest in Now - Insider Monkey
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Vor Bio Awards Massive 5.3M Share Package to New Development Chief: Full Grant Details Revealed - Stock Titan
Vor Biopharma shares rise 2.52% premarket after appointing Qing Zuraw as Chief Development Officer. - AInvest
Why Vor Biopharma Inc. stock is on top investor watchlistsFree Real-Time Market Predictions - Newser
Vor Bio Strengthens Leadership: Telitacicept Expert With Multiple Drug Approvals Joins as Development Chief - Stock Titan
Vor Bio Appoints Qing Zuraw, M.D. as Chief Development Officer - Yahoo Finance
Vor Biopharma Faces Crucial Market Shifts Amid Latest Developments - StocksToTrade
Vor Biopharma Stock Faces Volatile Week Amid Mixed Financial Reports - timothysykes.com
Vor Biopharma Inc. shares rise 2.00% premarket after Bonesupport CEO predicts strong growth. - AInvest
How Vor Biopharma Inc. stock performs during market volatilitySafe Entry High Exit Alerts - Newser
What makes Vor Biopharma Inc. stock price move sharplySteady Profit Stock Forecasts - Newser
Why Vor Biopharma Inc. stock attracts strong analyst attentionBreakout Confirmation Tool - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):